| NCT ID | NCT06213532 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 147 participants |
| Start Date | 2024-12-03 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 147 participants in total. It began in 2024-12-03 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates a smoking cessation intervention (CONNECTing to LungCare) for improving shared decision-making conversations about smoking cessation and lung cancer screening between patients and providers. Shared decision making is a patient care model in which providers offer information regarding risks and benefits, patients express their values and preferences, and then healthcare decisions are jointly discussed between the patient and provider. Patient education, aided by decision support tools, can increase patients' knowledge, decrease their decisional conflict, promote decision making, and improve the patients' perception of risk. CONNECTing to LungCare is an interactive education intervention that addresses lung cancer screening and smoking cessation and provides participants with a tailored summary that may make them more likely to have shared decision-making discussions with their providers about smoking cessation and lung cancer screening.
Eligibility Criteria
Inclusion Criteria: * English, Spanish and Cantonese speaking * Age \>= 18 years old * Primary care patients at the University of California, San Francisco (UCSF) General Internal Medicine (GIM) clinics * Must be current smokers and/or candidates for Lung Cancer Screening (LCS). Key Informant Interviews: \- Must be working in one of the clinics participating in CONNECTing to LungCare. Exclusion Criteria: * Not a current smoker
Contact & Investigator
Judith Walsh-Cassidy, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06213532 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06213532 currently recruiting?
Yes, NCT06213532 is actively recruiting participants. Contact the research team at lungcare@ucsf.edu for enrollment information.
Where is the NCT06213532 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT06213532 clinical trial?
NCT06213532 is sponsored by University of California, San Francisco. The principal investigator is Judith Walsh-Cassidy, MD at University of California, San Francisco. The trial plans to enroll 147 participants.